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Transurethral resection of exophytic bladder tumours (TURT) is the
first step in the management of bladder cancer. The procedure
confirms the diagnosis and provides important prognostic informa-
tion, including grading and staging of the disease. During
endoscopy, the tumour and underlying muscle are resected. This
procedure, performed under continuous irrigation, can lead to
passage of the irrigating fluid, accompanied by benign and/or
malignant epithelial cell suspensions, into the peripheral circula-
tion, facilitated by inevitable venous breaches during resection, and
by transient elevations of the intravesical pressure during resection
(Hahn, 1995). Theoretically, this may contribute to disease progres-
sion, invasion and metastases as has been suggested in other malig-
nancies, including breast and prostate cancer during open surgical
excision which has been shown to induce passage of normal and
malignant epithelial cells into the peripheral circulation (Eschwège
et al, 1995; Choy and McCulloch, 1996; Oeflein et al, 1996). To our
knowledge, however, haematogenous dissemination of epithelial
cells during endoscopic resection of bladder cancer or during cysto-
prostatectomy has not been studied previously.
The aim of our study was to evaluate prospectively the risk
of haematogenous dissemination of epithelial cells following
transurethral resection and cystoprostatectomy for bladder cancer.
PATIENTS, MATERIALS AND METHODS
Patients
Thirty-three patients were studied. Two were thought to have malig-
nant disease in the bladder, but were found to have non-specific
inflammation (n = 1) and schistosomiasis (n = 1) with no evidence
of malignancy. Thirty-one consecutive patients had different stages
and grades of transitional cell carcinoma of the bladder, 25 of whom
required transurethral resection of their bladder tumour. Of those, 20
had superficial disease (pTaG1–G2: n = 19; pT1G2: n = 1), all
tumours being single or multifocal with a total fresh weight less than
5 g, and no post-operative haemorrhagic complications; and five
had muscle invasive tumours (pT2G3: n = 2; pT3aG3: n = 1;
pT4G3: n = 2). Five of the remaining cancer patients underwent
radical cystoprostatectomy for muscle invasive cancers (pT2G3:
n = 3; pT3bG3: n = 1; pT4G3: n = 1). The final patient who was
analysed received a radical cystoprostatectomy 6 months earlier for
a pT4G3 tumour, and developed pelvic recurrence and skeletal
metastases. He was treated with systemic chemotherapy.
Sample collection and preparation
Venous blood samples (10 ml) were obtained by venepuncture
from the antecubital fossa in every patient before surgery, and
between 1 and 2 h after completion of the procedure. In the patient
with known metastatic disease, blood samples were obtained prior
to administration of chemotherapy.
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and resuspended in Dulbecco’s modified Eagle’s medium (Gibco,
UK). Mononuclear cells were isolated by Ficoll-hypaque (density
1.011), washed twice in PBS and resuspended at 1 ´ 106 mono-
nuclear cells ml–1 in PBS. Cells were spun at 0.5 ´ 106 cells per
slide in 0.5 ml. Cytospin slides were prepared using a centrifuge,
air-dried for 12–24 h and fixed in acetone for 10 min before
freezing. Five cytospins per sample were prepared, allowing the
analysis of a total of 2.5 3106 mononuclear cells for each sample.
Immunocytochemistry
Cytospin slides were incubated with a monoclonal antibody which
detects a common epitope of a variety of cytokeratin components,
including CK8, CK18 and CK19 (Micromet®, Martinsried,
Germany), expressed by bladder epithelial cells (Moll et al, 1982).
After incubation, the antibody reaction was developed using the
indirect immunoenzyme alkaline phosphatase anti-alkaline phos-
phatase (APAAP) technique. Red cytoplasmic staining of positive
cells was assessed by light microscopy. Slides were evaluated by
two independent observers (LDC and PB) in a double-blind fashion.
Validation studies
In order to test tumour cell losses during global processing, T24 (a
human urothelial carcinoma cell line derived from the American
Type Tissue Collection, T24 (Bubenik et al, 1973) (reference
ATCC HTB-1)) were spiked in whole heparinized blood samples,
to a density of 1 cell per 100 mononuclear cells. T24 cell recovery
was evaluated after Ficoll gradient extraction and immunocyto-
chemistry. Sensitivity of the technique was evaluated by spiking
T24 cells at different concentrations in mononuclear cells obtained
from healthy donors, ranging from 1 tumour cell per 105 mono-
nuclear cells to 1 tumour cell per 106 mononuclear cells.
Immunocytochemical internal control
T24 cells were mixed with heparinized blood from a healthy donor
to a density of 1 cell per 100 mononuclear cells. Cytospins were
prepared and labelled with the anti-pancytokeratine 8–19 mono-
clonal antibody.
RESULTS
Circulating epithelial cells
In all 33 patients who were studied, one blood sample showed
evidence of epithelial cells. This sample was obtained from the
patient with known metastatic disease who had not undergone
surgery immediately prior to blood sampling. All the other patients
had no evidence of any epithelial cells in the circulation.
Validation studies
Mean tumour cell recovery was 85% (mean of three experiments).
It was possible to detect up to 1 tumour cell per 5 ´ 105 mononu-
clear cells.
Immunocytochemical internal control
The T24 cell line was uniformly recognized after culture by the
anti-pancytokeratin 8–18 and 19 monoclonal antibody. Labelling
of the cytospins obtained from this culture constituted the
immunocytochemical positive control for all patient blood
samples tested.
DISCUSSION
To our knowledge, the detection of circulating epithelial cells after
urinary bladder surgery has not been studied previously. By using
an immunocytochemical detection technique, we showed that
neither endoscopic resection nor open surgery induced any
significant passage of epithelial cells into the bloodstream.
Immunocytochemical techniques based on the use of monoclonal
antibodies directed against cytokeratins have been used for a long
time to demonstrate circulating epithelial cells. Normal and
neoplastic bladder epithelial cells are known to express cytoker-
atins CK8, CK18 and CK19 (Moll et al, 1982; Carbin et al, 1987).
Soluble cytokeratin fragments, released by tumour cell necrosis,
can be detected in the blood or urine of patients with bladder
cancer. CYFRA 21-1 detects soluble fragments of CK19 (Senga et
al, 1996; Stieber et al, 1996), and tissue polypeptide antigen (TPA)
detects soluble fragments of CK8, CK18 and CK19 (Maulard et al,
1994; Sundstrom and Stigbrand, 1994). Serum CYFRA 21-1 and
TPA levels do not increase after endoscopic resection of bladder
tumours (Maulard et al, 1994; Senga et al, 1996), suggesting the
absence of any significant vascular passage of cell debris during
resection. These data support the results of our study.
Immunocytochemistry has demonstrated the presence of epithe-
lial cells in the efferent blood of kidney (Glaves et al, 1988) and
colonic tumours (Leather et al, 1993), and showed that surgical
resection of breast tumours could induce the passage of epithelial
cells into the distal venous blood circulation (Choy and
McCulloch, 1996). This technique can demonstrate circulating
epithelial cells beyond a density of 10 epithelial cells per ml of
blood. Like reverse transcription polymerase chain reaction (RT-
PCR) amplification, immunocytochemistry is able to detect in
vitro 1 in 106 mononuclear cells (Wood et al, 1994). Although RT-
PCR detection is a more sensitive technique than immunocyto-
chemistry at this low concentration (Wood et al, 1994), no ideal
RT-PCR amplification target is available for bladder epithelial
cells in vivo. RT-PCR amplification of cytokeratin mRNA can
induce a high risk of false-positives with CK8, CK18 and CK19
which, depending on the primers used, can be as high as 88% with
CK8 and 40% with CK19 (Burchill et al, 1995; Zippelius et al,
1997). Furthermore, RT-PCR and immunohistochemistry were
shown to have an equivalent sensitivity for demonstration of circu-
lating bone marrow aspirate epithelial cells based on cytokeratin
18 expression (Zippelius et al, 1997).
Uroplakin gene (Up Ib and UP III) expression has been demon-
strated recently by RT-PCR in the peripheral blood of patients with
metastatic bladder cancer (Yuasa et al, 1998). It is likely that these
genes will be useful and specific for urothelial cell detection in
peripheral blood in the near future, but at present immunocyto-
chemistry remains the reference technique for demonstration of
non-prostatic circulating epithelial cells.
For practical reasons, blood samples were obtained from the
antecubital fossa in our patients between 1 and 2 h after comple-
tion of endoscopic resection. Passage of circulating epithelial cells
released from a pelvic organ via the pulmonary circulation does
not prevent their detection in peripheral venous blood drawn from
the antecubital fossa. Moreover, when epithelial cells are released
from a tumour, they can be demonstrated in circulating blood for
up to 3 days after surgical handling of this tumour (Eschwège et al,
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1995; Oefelein et al, 1996). It is therefore unlikely for our protocol
to have reduced the sensitivity of the detection technique we used.
Our methods were validated further by the control experiments,
and the fact that the only positive patient had known metastatic
bladder cancer.
Despite the relatively small number of patients analysed,
various stages of the disease were investigated. Although the
biological behaviour of superficial bladder cancer differs from
invasive disease, some non-invasive cancers do progress and
metastasize, hence the importance of including this group of
patients in our study to assess the potential contribution of surgery
in the initiation of disease progression. Using the detection tech-
nique described, the results of our study suggest that irrespective
of disease stage, neither TURT nor cystoprostatectomy led to
significant dissemination of urothelial cells in the peripheral
blood. It is therefore unlikely that these procedures increase the
risk of distant metastases in patients with transitional cell carci-
noma of the bladder. Further studies comparing different epithelial
cell detection techniques in peripheral blood of patients with
bladder cancer are warranted to substantiate our findings.
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